The choice of the noninferiority margin in clinical trials was driven by baseline risk, type of primary outcome, and benefits of new treatment
Published inJournal of clinical epidemiology, vol. 68, no. 10, p. 1144-1151
Publication date2015
Abstract
Keywords
- Adult
- Confidence Intervals
- Cross-Sectional Studies
- Female
- Humans
- Male
- Middle Aged
- Models, Statistical
- Randomized Controlled Trials as Topic
- Research Personnel/psychology
- Sample Size
- Surveys and Questionnaires
- Treatment Outcome
Research groups
Citation (ISO format)
GAYET-AGERON, Angèle et al. The choice of the noninferiority margin in clinical trials was driven by baseline risk, type of primary outcome, and benefits of new treatment. In: Journal of clinical epidemiology, 2015, vol. 68, n° 10, p. 1144–1151. doi: 10.1016/j.jclinepi.2015.01.017
Main files (1)
Article (Published version)
Identifiers
- PID : unige:90339
- DOI : 10.1016/j.jclinepi.2015.01.017
- PMID : 25716902
Journal ISSN0895-4356
